Drugs / 18F-Fludeoxyglucose (18F-FDG)
18F-Fludeoxyglucose (18F-FDG)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00375830 | Jan 2006 → Apr 2017 | cancer | Stanford University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-Fludeoxyglucose (18F-FDG) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00375830 ↗ |
| Modality | Diagnostic / imaging agent | “Radiolabel for positron emission tomography scan procedures” NCT00375830 ↗ |